Tuesday, 22 May 2018

Natco launches generic drug for sclerosis in India

05 April 2018 | News

The company has launched the product under brand name 'Denopsy'

Image Courtesy- medscape.com

Image Courtesy- medscape.com

Drug firm Natco Pharma has launched a generic version of Teriflunomide tablets used for the treatment of relapsing and remitting forms of multiple sclerosis in India.

The company has launched the product under brand name 'Denopsy', Natco Pharma said.

"This is the first oral medicine for relapsing and remitting forms of multiple sclerosis being offered in India at two different strengths - 14 mg and 7 mg tablets" it added.

Teriflunomide is sold by Sanofi-Genzyme under the brand name of Aubagio in the US market, Natco Pharma said. 

The generic product is priced much lower than other alternate options in India.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account





Survey Box

Does India need to talk about Mental Health?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls